Complex cytogenetic abnormalities in chronic myeloid leukemia resulting in early progression to blast crisis: a case report

INTRODUCTION: BCR-ABL1, resulting from t(9;22), is the oncogenic driver of chronic myeloid leukemia and the therapeutic target of the disease. Molecular studies have been the gold standard modality for patient assessment since the advent of tyrosine kinase inhibitor therapy. In spite of that, there...

Descripción completa

Detalles Bibliográficos
Autores principales: Malakzai, Haider Ali, Rahmani, Soma, Haidary, Ahmed Maseh, Noor, Sarah, Ahmad, Maryam, Ibrahimkhil, Abdul Sami, Sharif, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694935/
https://www.ncbi.nlm.nih.gov/pubmed/33243265
http://dx.doi.org/10.1186/s13256-020-02539-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694935/
https://www.ncbi.nlm.nih.gov/pubmed/33243265
http://dx.doi.org/10.1186/s13256-020-02539-x

Ejemplares similares